dihydrotetrabenazine has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassett, AS; Boot, E; Butcher, NJ; Chow, EWC; Christopher, L; Fritsch, R; Lang, AE; Marras, C; Masellis, M; Pondal, M; Repetto, GM; Rusjan, P; Strafella, AP | 1 |
| Agid, Y; Darchen, F; Desnos, C; Javoy-Agid, F; Pollak, P; Scherman, D | 1 |
2 other study(ies) available for dihydrotetrabenazine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Topics: Adult; Carbon Radioisotopes; Case-Control Studies; Corpus Striatum; DiGeorge Syndrome; Female; Functional Neuroimaging; Humans; Hypertrophy; Male; Parkinson Disease, Secondary; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine; Ultrasonography, Doppler, Transcranial | 2017 |
Striatal dopamine deficiency in Parkinson's disease: role of aging.
Topics: Aged; Aging; Corpus Striatum; Dopamine; Humans; Parkinson Disease, Secondary; Tetrabenazine | 1989 |